Positron Recieves Radioactive Materials License from Nuclear Regulatory Commission

Monday March 1, 2010, 1:46 pm

INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC - News) a molecular imaging solutions company focused on Nuclear Cardiology, announced today that the Nuclear Regulatory Commission has licensed the Positron facility in Fishers, Indiana to handle radioactive material. Positron Corporation and staff demonstrated the necessary expertise and protocol to receive this license. A radioactive material handling license allows Positron to test equipment and develop new technologies, including pharmaceuticals. “A radioactive material license directly benefits our current product line and increases our ability to deliver new technologies,” stated John A. Zehner, Positron Corporation, COO and Radiation Safety Officer. “The ability to handle radioactive material will enhance our sales efforts, allow new revenue streams, as well as, offer new opportunities to partner with pharmaceutical companies, Government agencies, inventors and universities.”

About Positron: Positron founded in 1983, is a molecular imaging company focused on Nuclear Cardiology. Positron utilizes its proprietary product line to provide unique solutions to the Nuclear Medicine community ranging from imaging systems to radiopharmaceutical distribution. Positron products include: the Attrius™, a PET imaging device; the Pulse®, a SPECT imaging device; the Nuclear Pharm-Assist®, an automated radiopharmaceutical distribution device; and the Tech-Assist™, a radiopharmaceutical injection shield. Positron is headquartered in Indianapolis, Indiana. More information about Positron is available at www.positron.com.

Forward Looking Statements: Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.

For further information please contact Positron Corporation at (317) 576-0183.